Clinical Research Directory
Browse clinical research sites, groups, and studies.
Risk Assessment for HBV-Related Liver Cancer
Sponsor: Sun Yat-sen University
Summary
Liver cancer is a severe disease worldwide. The incidence and mortality rates of liver cancer in China is the highest in the world. This project aims to perform a prospective, multi-center, large sample cohort study for HBV related high-risk individuals. Based on multimodal data fusion and AI technique, stratified management and follow-up system are conducted for HBV-related high-risk populations of liver cancer, in order to improve the early diagnosis rate of liver cancer.
Official title: Research on Risk Assessment and Intervention of HBV-Related Liver Cancer Based on Multimodal Data Fusion
Key Details
Gender
All
Age Range
30 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
6000
Start Date
2025-05-10
Completion Date
2032-12-30
Last Updated
2025-09-08
Healthy Volunteers
No
Conditions
Interventions
AI folow-up system
In AI follow-up group, patients will be followed up by an AI system.
Locations (1)
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China